FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 26.33

Change

+0.23 (+0.88)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-23 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+2.84 (+2.51%)

USD 16.21B
VOT Vanguard Mid-Cap Growth Index ..

+4.90 (+2.09%)

USD 14.12B
IJK iShares S&P Mid-Cap 400 Growth..

+1.33 (+1.68%)

USD 7.96B
XMMO Invesco S&P MidCap Momentum ET..

+2.03 (+1.85%)

USD 3.25B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+2.03 (+2.07%)

USD 0.98B
ETHO Amplify ETF Trust

+1.10 (+2.17%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

+0.36 (+0.57%)

USD 0.17B
BFOR Barron's 400 ETF

+1.05 (+1.58%)

USD 0.14B
IPO Renaissance IPO ETF

+1.31 (+3.68%)

USD 0.12B
PEXL Pacer US Export Leaders ETF

+0.90 (+2.13%)

USD 0.04B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.90% 81% B- 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.90% 81% B- 35% F
Trailing 12 Months  
Capital Gain 1.54% 63% D 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.54% 63% D 42% F
Trailing 5 Years  
Capital Gain -11.32% 11% F 24% F
Dividend Return 2.88% 17% F 6% D-
Total Return -8.43% 6% D- 14% F
Average Annual (5 Year Horizon)  
Capital Gain -3.52% 17% F 19% F
Dividend Return -2.83% 17% F 13% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 27.45% 17% F 36% F
Risk Adjusted Return -10.30% 11% F 17% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.